These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21265983)

  • 21. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.
    Silberstein S; Diener HC; Lipton R; Goadsby P; Dodick D; Bussone G; Freitag F; Schwalen S; Ascher S; Morein J; Greenberg S; Biondi D; Hulihan J
    Headache; 2008 Jul; 48(7):1087-95. PubMed ID: 18687081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate may not increase risk of urolithiasis: A nationwide population-based cohort study.
    Shen AL; Lin HL; Tseng YF; Lin HC; Hsu CY; Chou CY
    Seizure; 2015 Jul; 29():86-9. PubMed ID: 26076848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Topiramate related REM sleep behavior disorder].
    Más Sesé G; Pamblanca-Bataller Y; Roig-Morata S
    Neurologia; 2009 May; 24(4):280. PubMed ID: 19950425
    [No Abstract]   [Full Text] [Related]  

  • 24. Topiramate-induced reversible auditory hallucination.
    Uzar E; Kutluhan S; Yurekli VA; Ilhan A
    Epileptic Disord; 2008 Sep; 10(3):240. PubMed ID: 18833667
    [No Abstract]   [Full Text] [Related]  

  • 25. Utilization of topiramate during pregnancy and risk of birth defects.
    Green MW; Seeger JD; Peterson C; Bhattacharyya A
    Headache; 2012; 52(7):1070-84. PubMed ID: 22724387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topiramate (Topamax) for prevention of migraine.
    Med Lett Drugs Ther; 2005 Jan; 47(1201):9-10. PubMed ID: 15678014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Forced Normalization": Could It Occur Also in Migraine Patients?
    Russo A; Silvestro M; Tessitore A; Tedeschi G
    Headache; 2017 May; 57(5):803-805. PubMed ID: 28390100
    [No Abstract]   [Full Text] [Related]  

  • 28. Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective.
    Alore PL; Jay WM; Macken MP
    Semin Ophthalmol; 2006; 21(1):15-7. PubMed ID: 16517439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of newer antiepileptic drugs.
    Racoosin JA; Knudsen JF
    JAMA; 2004 May; 291(17):2074; author reply 2074. PubMed ID: 15126428
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V; Biondi D; Pfeil J; Schwalen S
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible tremor, myoclonus, and fasciculations associated with topiramate use for migraine.
    Alonso-Navarro H; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2006; 29(3):157-9. PubMed ID: 16772816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral acute angle-closure glaucoma in a migraine patient receiving topiramate: a case report.
    Cole KL; Wang EE; Aronwald RM
    J Emerg Med; 2012 Aug; 43(2):e89-91. PubMed ID: 20005660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Migraine prophylaxis with topiramate and bone health in women.
    Ali II; Herial NA; Orris M; Horrigan T; Tietjen GE
    Headache; 2011 Apr; 51(4):613-6. PubMed ID: 21457246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible hypohidrosis with topiramate therapy for chronic migraine.
    Markowitz SY; Robbins MS; Cascella C; Sheikh HU; Grosberg BM
    Headache; 2010 Apr; 50(4):672-4. PubMed ID: 20236344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical use of topiramate for migraine prevention.
    Brandes JL
    Headache; 2005 Apr; 45 Suppl 1():S66-73. PubMed ID: 15833092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible anorgasmia with topiramate for migraine prophylaxis.
    Coebergh JA; Waldinger MD
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):E30-1. PubMed ID: 22772690
    [No Abstract]   [Full Text] [Related]  

  • 39. Dramatic improvement of fibromyalgia symptoms after treatment with topiramate for coexisting migraine.
    Kararizou E; Anagnostou E; Triantafyllou NI
    J Clin Psychopharmacol; 2013 Oct; 33(5):721-3. PubMed ID: 23948791
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effectiveness of topiramate in the treatment of childhood migraine].
    Fang J; Wang ZC
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):509-10. PubMed ID: 17178049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.